Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: Correlation between elevated serum interleukin-1β, interleukin-16 levels and psychiatric symptoms in patients with schizophrenia at different stages

Project

FEG (n = 40)

REG (n = 40)

HP (n = 36)

χ2/t

P

Gender

  Male

12(30)

13(32.5)

14(38.9)

0.71

0.703

  Female

28(70)

27(67.5)

12(61.1)

Age

  <age of 45

34(85)

35(87.5)

35(97.2)

3.33

0.189

  ≥age of 45

6(15)

5(12.5)

1(2.8)

Marital status

  Married

22(55)

14(35)

11(30.5)

5.47

0.065

  Single

18(45)

26(65)

25(69.5)

Education life

  ≤ 6 years

9(22.5)

8(20)

2(5.5)

4.52

0.105

  >6 years

31(77.5)

32(80)

34(94.5)

Domicile

  City

15(37.5)

17(42.5)

19(52.7)

1.85

0.400

  Town

25(62.5)

23(57.5)

17(47.3)

  BMI(kg/m2)

23.13(3.25)

23.92(5.08)

22.60(2.96)

1.11

0.334

  First onset of Disease (age)

28.5(12.0)

32.2(13.0)

/

0.19

0.846

  Total course (years)

2.54(1.36)

2.70(1.30)

/

0.46

0.649

  PANSS(points)

89.60(10.85)

83.43(21.02)

/

1.65

0.103

  BPRS(points)

50.05(10.24)

46.93(8.91)

/

1.46

0.149

  1. BMI Body Mass Index, PANSS Positive and Negative Symptom Scale, BPRS Brief Psychiatric Rating Scale